The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Parkinson’s, Autoimmune Disorders May Share Genetic Common Ground

Parkinson’s, Autoimmune Disorders May Share Genetic Common Ground

June 12, 2017 • By Joan Stephenson

  • Tweet
  • Email
Print-Friendly Version / Save PDF

NEW YORK (Reuters Health)—Parkinson’s disease and some autoimmune diseases may have genetic risk factors in common, raising the possibility that the immune system may influence Parkinson’s disease pathogenesis, new research suggests.

You Might Also Like
  • Genes Connect Parkinson’s Disease to Autoimmune Diseases
  • The Genetic Factor: Research Examines Genetic Heritability for Pediatric Autoimmune Diseases
  • Large Genome Study Identifies Genetic Risk Factors for Gout

The study, which analyzed data from genome-wide association studies, “showed a considerable genetic overlap between [Parkinson’s disease] and autoimmune diseases, in particular, type 1 diabetes, Crohn’s disease and rheumatoid arthritis,” corresponding author Dr. Manu Sharma of the Centre for Genetic Epidemiology at the University of Tubingen, Germany, tells Reuters Health by email.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Previous research has pointed to an association between inflammation and neurodegenerative diseases, including Alzheimer’s disease and Parkinson’s disease. Clinical studies have also found a lowered risk of PD in people who regularly use nonsteroidal anti-inflammatory drugs.

However, studies have yielded conflicting results with respect to a potential immune component in Parkinson’s disease, Dr. Sharma says.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

To investigate, the researchers used existing data sets from genome-wide association studies (GWAS) in PD and from seven autoimmune disorders (type 1 diabetes, Crohn’s disease, ulcerative colitis, rheumatoid arthritis, celiac disease, psoriasis and multiple sclerosis).

Using an approach called conjunctional false discovery rate analysis, the investigators analyzed GWAS data involving more than 138,000 individuals of European ancestry in search of pleiotropic gene loci, or markers, associated with both PD and the autoimmune disorders.

The analysis identified 17 novel “shared susceptibility loci” with overlap between Parkinson’s disease and the seven autoimmune diseases, the researchers report in JAMA Neurology, online June 5.1

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

Analysis of an independent data set involving nearly 7,000 Parkinson’s disease cases and about 6,100 controls confirmed that five of these loci were involved in Parkinson’s disease. Some of the genes within the identified loci had been independently implicated in Parkinson’s disease or Crohn’s disease.

The newly identified shared loci play a role in immune system functions, transcriptional function and regulation, and signaling pathways.

The researchers also investigated biological correlation between loci through analyses of protein-protein interaction and changes in expression and methylation levels of immune-function-related genes in the brain.

“The network analysis showed functional relatedness of genes implicated in our study,” Dr. Sharma says, noting that further functional studies are needed to understand the underlying pathways for Parkinson’s disease and autoimmune disorders.

The findings suggest “that extensive clinical studies for monitoring immune and inflammation status in patients with autoimmune [diseases] should be pursued to identify at-risk subjects for [Parkinson’s disease] and vice versa,” he says.

“Although the study . . . provides additional evidence for a mechanistic role of the immune system in [Parkinson’s disease], there are caveats to these types of studies that limit the certainty of the conclusions that can be drawn,” write Drs. Nikolaus R. McFarland, Karen N. McFarland and Todd E. Golde of the University of Florida in Gainesville, in an accompanying editorial.2

Pages: 1 2 | Single Page

Filed Under: Conditions Tagged With: Autoimmune disease, genome, Parkinson’s Disease

You Might Also Like:
  • Genes Connect Parkinson’s Disease to Autoimmune Diseases
  • The Genetic Factor: Research Examines Genetic Heritability for Pediatric Autoimmune Diseases
  • Large Genome Study Identifies Genetic Risk Factors for Gout
  • Autoimmune Diseases Common in Patients with Vitiligo

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)